
Biomedcode is a CRO with extensive expertise in efficacy evaluation studies using standardized preclinical platforms of inflammatory and fibroproliferative diseases as well as cancer. Biomedcode combines scientific consultation and custom-tailored solutions towards optimizing the validation procedure of novel human therapeutics including biologics, biosimilars, biobetters and small molecules. Offered services include animal disease model development, in-vivo and ex-vivo preclinical drug evaluation, PK/PD analysis, standardized sample collection and analysis, histopathology,…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.